$0.589700
-0.03-4.42%
At close: -
$1.10
0.5186.50%
After Hours: 7:59 PM EDT
Comments
Loading...
Virpax Pharmaceuticals (VRPX) Forecast
NewsEarningsVirpax Pharmaceuticals (VRPX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVirpax Pharmaceuticals (NASDAQ:VRPX) Stock Quotes, Forecast and News Summary
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Virpax Pharmaceuticals (VRPX) stock?
You can purchase shares of Virpax Pharmaceuticals (NASDAQ:VRPX) through any online brokerage.
Who are Virpax Pharmaceuticals (VRPX) competitors?
Other companies in Virpax Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
What is the forecast, or price target, for Virpax Pharmaceuticals (VRPX) stock?
There is no analysis for Virpax Pharmaceuticals to provide a consensus price target.
What is the current price for Virpax Pharmaceuticals (VRPX)?
The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $1.0998 last updated November 21, 2024 at 7:59 PM EST.
Does Virpax Pharmaceuticals (VRPX) pay a dividend?
There are no upcoming dividends for Virpax Pharmaceuticals.
When is Virpax Pharmaceuticals (NASDAQ:VRPX) reporting earnings?
Virpax Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Virpax Pharmaceuticals (VRPX) going to split?
There is no upcoming split for Virpax Pharmaceuticals.
What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?
Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.